T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2B |
| 2 |
Sea Limited
SE
|
+$1.34B |
| 3 |
Morgan Stanley
MS
|
+$1.23B |
| 4 |
Incyte
INCY
|
+$1.05B |
| 5 |
Ross Stores
ROST
|
+$968M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.05B |
| 2 |
VMW
VMware, Inc
VMW
|
+$1.5B |
| 3 |
Visa
V
|
+$1.16B |
| 4 |
JPMorgan Chase
JPM
|
+$1.13B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.01% |
| 2 | Healthcare | 17.6% |
| 3 | Consumer Discretionary | 14.37% |
| 4 | Financials | 11.89% |
| 5 | Communication Services | 10.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
D.R. Horton
DHI
$41.9B
| $34.6M | ﹤0.01% |
624,231
-54,902
| -8% | -$2.66M |
|
|
ABMD
977
DELISTED
Abiomed Inc
ABMD
| $34.6M | ﹤0.01% |
143,167
-25,971
| -15% | -$5.21M |
|
978
Suncor Energy
SU
$76.5B
| $34.4M | ﹤0.01% |
2,042,719
-9,558,331
| -82% | -$163M |
|
979
Stoneridge
SRI
$201M
| $34.1M | ﹤0.01% |
1,648,891
+1,760
| +0.1% | +$33K |
|
|
BERY
980
DELISTED
Berry Global Group, Inc.
BERY
| $33.8M | ﹤0.01% |
830,183
-578,645
| -41% | -$21.7M |
|
981
Host Hotels & Resorts
HST
$15.6B
| $33.8M | ﹤0.01% |
3,130,031
-2,241,557
| -42% | -$25.7M |
|
982
Bio-Techne
TECH
$11.2B
| $33.7M | ﹤0.01% |
510,076
+430,756
| +543% | +$25.8M |
|
983
Ligand Pharmaceuticals
LGND
$5.76B
| $33.1M | ﹤0.01% |
474,655
-38,821
| -8% | -$2.46M |
|
984
Agnico Eagle Mines
AEM
$91.3B
| $33M | ﹤0.01% |
517,812
-93,333
| -15% | -$5.53M |
|
|
HBI
985
DELISTED
Hanesbrands
HBI
| $32.8M | ﹤0.01% |
2,904,008
+297,151
| +11% | +$2.97M |
|
|
RDFN
986
DELISTED
Redfin
RDFN
| $32.6M | ﹤0.01% |
778,091
+1,690
| +0.2% | +$44.5K |
|
987
Moog Inc Class A
MOG.A
$13.5B
| $32.6M | ﹤0.01% |
615,347
-2,370
| -0.4% | -$122K |
|
|
EPZM
988
DELISTED
Epizyme, Inc
EPZM
| $32.6M | ﹤0.01% |
2,027,247
+645,097
| +47% | +$11.3M |
|
989
Merit Medical Systems
MMSI
$5.4B
| $32.5M | ﹤0.01% |
713,025
-1,347
| -0.2% | -$54.4K |
|
|
CIR
990
DELISTED
CIRCOR International, Inc
CIR
| $32.5M | ﹤0.01% |
1,274,544
-536,267
| -30% | -$8.35M |
|
991
Akamai
AKAM
$18B
| $32.4M | ﹤0.01% |
302,964
-25,180
| -8% | -$2.53M |
|
992
Arcutis Biotherapeutics
ARQT
$3.25B
| $32.3M | ﹤0.01% |
1,066,540
+85,926
| +9% | +$2.48M |
|
|
NARI
993
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $32.2M | ﹤0.01% |
+663,734
| New | +$31.7M |
|
994
APA Corp
APA
$14B
| $32.1M | ﹤0.01% |
2,380,716
-2,614,959
| -52% | -$29.8M |
|
995
LyondellBasell Industries
LYB
$20.2B
| $32.1M | ﹤0.01% |
488,112
-35,840
| -7% | -$2.13M |
|
996
Delta Air Lines
DAL
$60B
| $31.8M | ﹤0.01% |
1,134,498
-126,164
| -10% | -$3.21M |
|
997
Pinterest
PINS
$13.2B
| $31.7M | ﹤0.01% |
1,429,631
-545,597
| -28% | -$10.6M |
|
998
Pebblebrook Hotel Trust
PEB
$2.05B
| $31.7M | ﹤0.01% |
2,319,172
-236,967
| -9% | -$2.93M |
|
999
Chewy
CHWY
$9.2B
| $31.6M | ﹤0.01% |
706,280
-662,448
| -48% | -$28.9M |
|
|
K
1000
DELISTED
Kellanova
K
| $31.6M | ﹤0.01% |
508,766
-951,970
| -65% | -$57.6M |
|
Similar funds
T. Rowe Price Associates's Q2 2020 Portfolio in Review
As of Q2 2020, T. Rowe Price Associates held 2,591 positions worth $795B, up 26% from $632B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
T. Rowe Price Associates's Q2 2020 filing shows 79 new, 1,096 increased, 1,255 reduced and 100 closed positions. Its largest new stake was Vroom Inc: 200,362 shares worth $797M. The largest sale was Boeing, an estimated $2.05B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2020 buy was Vroom Inc: 200,362 shares worth $797M.
- T. Rowe Price Associates added most to Microsoft in Q2 2020, an estimated $2B increase.
- T. Rowe Price Associates's biggest Q2 2020 reduction was Boeing, cutting an estimated $2.05B.
- T. Rowe Price Associates fully exited Raytheon Company in Q2 2020, selling an estimated $1.01B.
- T. Rowe Price Associates's ten largest holdings make up 25% of its $795B portfolio in Q2 2020.
- T. Rowe Price Associates opened 79 new positions and closed 100 in Q2 2020.
- T. Rowe Price Associates's portfolio value rose 26% quarter-over-quarter to $795B.
Based on T. Rowe Price Associates's 13F filing for Q2 2020, filed 14 Aug 2020.